Results 211 to 220 of about 229,801 (281)

Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma [PDF]

open access: yes, 1994
Bogner, Johannes R.   +6 more
core  

Exome Sequencing Reveals a Sparse Genomic Landscape in Kaposi Sarcoma. [PDF]

open access: yesMol Cancer Res
Phipps W   +7 more
europepmc   +1 more source

Disseminated Kaposi Sarcoma With Ocular Involvement: An Unusual Multisystem Case Presentation. [PDF]

open access: yesCureus
Torralbas Fitz AL   +4 more
europepmc   +1 more source

Kaposi Sarcoma Updates.

Dermatologic Clinics, 2019
Kaposi sarcoma (KS) is an angioproliferative mesenchymal neoplasm caused by Kaposi sarcoma-related herpesvirus. This review outlines our current understanding of the epidemiology, pathogenesis, clinical presentation, and staging for this disease.
Shervin A. Etemad, Anna K. Dewan
semanticscholar   +3 more sources

Global patterns and trends in Kaposi sarcoma incidence: a population-based study.

Lancet Global Health, 2023
BACKGROUND Kaposi sarcoma is a rare, possibly angioproliferative, tumour. Kaposi sarcoma is one of the most common cancers in people living with HIV and poses a serious public health challenge in regions with high HIV burden.
Leiwen Fu   +9 more
semanticscholar   +1 more source

Kaposi's sarcoma

Cancer, 1966
Sixty three patients with Kaposi's sarcoma (1935–1963) have been reviewed. Of this group 18 patients died of a secondary primary. The second primaries included 5 cases of Hodgkin's disease, 3 of lymphosarcoma, 3 of carcinoma of the colon and one each of multiple myeloma, malignant melanoma, carcinoma of the prostate, carcinoma of the tongue, carcinoma ...
P H, O'Brien, R D, Brasfield
openaire   +2 more sources

Kaposi's Sarcoma

New England Journal of Medicine, 2000
In 1872, Moritz Kaposi, a Hungarian dermatologist, described five men with aggressive “idiopathic multiple pigmented sarcomas of the skin.”1 One patient died of gastrointestinal bleeding 15 months after the initial appearance of the skin lesions, and an autopsy showed visceral lesions in the lungs and the gastrointestinal tract.
K, Antman, Y, Chang
openaire   +2 more sources

Update on oncogenesis and therapy for Kaposi sarcoma.

Current Opinion in Oncology, 2019
PURPOSE OF REVIEW This review is an update of the recent findings on pathophysiology of Kaposi sarcoma, the role of HHV-8 in Kaposi sarcoma pathogenesis and to summarize the recent advances in the treatment of Kaposi sarcoma and the role of immunity to ...
N. Dupin
semanticscholar   +1 more source

Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant

International Journal of Dermatology, 2018
Kaposi sarcoma (KS) is a rare angioproliferative tumor whose etiology is associated with human herpesvirus 8 (HHV 8). KS lesions typically involve the skin or mucosal surfaces and are characterized by purplish, red‐blue, or brown‐black macules, papules ...
R. Vangipuram, S. Tyring
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy